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Abstract Effect of human prothymosin ¢~ and its mutant over- 
produced in S. cerevisiae on yeast cell division was studied. Wild- 
type prothymosin a appeared to block division of yeast cells. Its 
inhibitory action could be abolished by deletion of the last nine 
carboxy-terminal mino acids of prothymosin a containing nu- 
clear localization signal, thus pointing to the nucleus as a com- 
partment, where prothymosin a performs its action. 
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1. Introduction 
Prothymosin a (ProTa) is a highly acidic protein of 13 kDa, 
which is thought o be a precursor of thymosin al ,  a putative 
thymic hormone [1]. However, accumulating evidence suggests 
that, apart from its immunomodulating activity, ProTct pro- 
vides some general function within the cell, most probably 
related to cell division [2-5]. In accord with this notion is the 
presence of the karyophilic sequence in the ProTa molecule 
[6,7] responsible for the nuclear targeting of the protein, and 
ubiquity of ProTa in various tissues and species, including 
unicellular organisms such as yeast [8]. 
Here, human ProTcz was produced in yeast S. cerevisiae, and 
its effect on yeast cell division was studied. Wild type human 
ProT~ appeared to block division of yeast cells. Most notably, 
deletion of the carboxy-terminal uclear localization signal of 
the protein abolished this inhibitory effect. 
2. Materials and methods 
Escherichia coli JM109 and Saccharomyces cerevisiae SKY594 
[MATa, leu2-3, 112, lysT, ura3-52 (cir+)] and 2805 [MATa, pep4:: His3, 
prb 1-~, canl, Gal2, his3d;, ura3-52] strains were used throughout this 
work. 
Yeast shuttle vector pYeDPI/8-2 [9] was kindly provided by D. 
Pompon. Construction of pYeHT1 containing human ProTct cDNA 
inserted into BamHI and KpnI sites of pYeDPI/8-2 was described in 
[10]. To obtain DNA fragment coding for ProTa lacking karyophilic 
signal, aPCR was performed on pYeHT1 with primers (5'-dATGTCA- 
GACGCAGCCGTAGA-3') and (5'-dCTAGGTATCGACATCGTC- 
ATC-3') corresponding to the very amino-terminus of ProTa and to the 
carboxy-terminal region of the protein excluding the last nine amino 
acid residues, respectively. A 303 bp long PCR product was inserted 
into the Sinai site of pUC19, sequenced, and then recloned into the 
BamHI-KpnI sites of pYeDP 1/8-2 yielding pYeKHT 1. Construction of
the plasmid encoding ProTa with three point mutations [SerIThr, 
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Asn39Asp, LysSVGlu] will be described elsewhere (Yu.R. and A.V., man- 
uscript in preparation). 
Yeast cells were transformed with the plasmids by electroporation 
[11]. For induction of GAL10-CYC1 promoter, cultures grown in glu- 
cose-containing SD medium (2% glucose, 0.67% yeast nitrogen base, 
0.1% casamino acids) supplemented with 30 ~tg/ml L-lysin and 60 ug/ml 
L-leucine were washed twice with the same medium containing 2% 
galactose instead of glucose, resuspended in this medium, and grown 
at 30°C. 
The percentage of cells that survive galactose treatment was deter- 
mined by the colony-forming-unit test essentially as described in [12]. 
Procedure for ProTa isolation was as follows. The cells were lysed 
in lysis buffer containing 6 mM Tris-HC1 (pH 6.8), 10% SDS, 2% 
fl-mercaptoethanol at 100°C for 3 rain. An equal volume of hot (100°C) 
phenol saturated with 20 mM ammonium acetate (pH 4.5), 10 mM 
EDTA, 0.5% SDS was added, vortexed and incubated at 100°C for 
2 min and then at 0°C for 10 rain. After centrifugation the precipitate 
of cell debris was discarded and approx, one-third volume of chloro- 
form was added to the supernatant for phase separation. The upper 
aqueous phase was re-extracted with saturated phenol and mixed with 
one-fifth volume of 3 M sodium acetate (pH 5.2). This resulted in a new 
separation of phases. ProTct was precipitated from the lower phenol 
phase with 3 volumes of ethanol, washed with ethanol, dried and dis- 
solved in water. The sample was extracted twice with phenol/chloro- 
form/TE and precipitated with ethanol. Electrophoresis of ProTa in 8% 
polyacrylamide g ls containing 7 M urea was performed according to 
the standard technique employed for nucleic acid analysis [13]. The gels 
were stained with 0.2% Methylene blue in 50 mM ammonium acetate 
(pH 4.5) for 5 min, briefly destained with water, and immediately 
photographed. 
3. Results 
3.1. Production of human ProTa in S. cerevisiae 
In order to test the effect of human ProTa on division of 
yeast S. cerevisiae cells, the protein-coding regions of cDNAs 
coding for the wild type human ProTct and its mutated form 
lacking nine C-terminal amino acids including nuclear localiza- 
tion signal were cloned into the pYeDP1/8-2 shuttle vector 
under the control of GAL10-CYC1 promoter, which could be 
induced by growing yeast cells in the galactose-containing me-
dium [9]. 
Yeast cells bearing the appropriate plasmids were grown in 
glucose-containing medium and then shifted to the galactose- 
containing medium to induce transcription of ProT~ cDNA. 
ProT~ was isolated from these cells 18 hours after induction 
and subjected to analysis. Polyacrylamide gel electrophoresis 
commonly used for nucleic acid sequencing in conjunction with 
ProTa staining with nucleic acid-specific dye Methylene blue 
appeared to be an ideal means for ProT~ analysis due to the 
impressive negative charge of this highly acidic protein. Fig. 1 
demonstrates that both wild type ProTa and ProTa lacking 
nine C-terminal amino acids including nuclear localization sig- 
nal were produced in S. cerevisiae, their electrophoretic mobili- 
ties being dependent upon the size of the respective protein. 
Identity of the overproduced protein with ProTct was con- 
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Fig. 1. Synthesis of human ProT~ (1) and its truncated form (2) in yeast. (A) Schematic diagram of overproduced proteins; ProT~ sequence which 
is absent in its truncated form is shown in the single-letter amino acid code; amino acids are numbered from the N-terminus; NLS, nuclear localization 
signal. (B) Electrophoretic analysis of wild type and truncated human ProT~ isolated from equivalent amounts of yeast cells. 
firmed by its amino acid analysis. No ProT~ was observed 
when the cells were grown in the absence of the inducer (not 
shown) due to the low level of the endogeneous protein in yeast 
[8]. Thus both wild type human ProTc~ and its truncated form 
could be synthesized in S. cerevisiae in regulatable fashion. 
Besides, ayeast strain producing human ProT~ with three point 
mutations [SerlThr0 Asn39Asp, LysS7Glu] was obtained and 
proved to synthesize mutated human protein with high effi- 
ciency (not shown). 
3.2. Fate of S. cerevisiae cells producing human prothymosin 
Behaviour of S. cerevisiae cells synthesizing ProT~ was as- 
sessed by growing yeast cells bearing the respective plasmids in 
the galactose-containing medium. While in the absence of in- 
ducer the cells transformed with pYeHTI, pYeKHT1 and the 
vector pYeDPI/8-2 grew equally well, production of the wild 
type human ProT~ resulted in severe inhibition of cell growth 
(Fig. 2). The inhibitory action of human ProT~ on yeast cell 
growth appeared to be reversible: withdrawal of the inducer 
from the medium abolished transcription of the human ProT~ 
gene and restored cell division. Thus, overproduction f human 
ProT~ caused arrest of yest cell growth but not cell death, as 
was additionally confirmed by colony-forming- unit test (not 
shown). 
Surprisingly, block of yeast cell division observed with wild 
type ProT~ was almost completely abrogated by deletion of 
nine carboxy-terminal amino acids bearing the nuclear localiz- 
ation signal. Indeed, yeast cells synthesizing truncated ProT~ 
produced even more protein as compared to the cells synthesiz- 
ing wild type ProT~ (see Fig. 1) and yet grew quite well 
(Fig. 2). Also, no growth inhibition was observed in case of the 
cells producing triple ProTc~ mutant (not shown). 
4. Discussion 
Although function of ProT~ is obscure, evidence is emerging 
that this protein is involved in proliferation of mammalian cells 
[2 5]. Since ProT~ is highly evolutionary conserved and a ho- 
mologous protein exists in yeast [8], we attempted to address 
ProT~ function using yeast S. cerevisiae as an alternative exper- 
imental system. In the absence of cloned yeast ProT~ gene, we 
employed human ProTc~ cDNA for production of human 
ProT~ in yeast. We argued that if yeast ProTc~ were related to 
cell division as well, interference of homologous but probably 
somewhat different human ProTc~ should impair division of 
yeast cells. This indeed turned out to be the case: production 
of human ProT~ reversibly blocked yeast cell division. This 
inhibitory effect was not due to production of a significant 
amount of the plasmid-encoded protein per se, since synthesis 
of truncated ProTc~ at the level exceeding that of wild type 
protein exerted no effect on cell growth. Further evidence for 
the specificity of action of human ProT~ came from the behav- 
iour of yeast cells producing triple ProT~ mutant, which still 
retained characteristic acidity of the protein and its nuclear 
localization signal, and yet turned out to be inactive in suppres- 
sion of yeast cell growth. 
Most interestingly, inhibitory action of human ProT~ on 
yeast cell growth was abrogated by deletion of just nine car- 
boxy-terminal mino acids of the protein. This fact has interest- 
ing implications because the region in question contains karyo- 
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Fig. 2. Growth of yeast cells (SKY594) producing: 1, wild type human ProTon, 2, truncated ProTc~, 3, no ProT0~ (vector alone) in the galactose- 
containing medium. 
philic sequence targeting ProT~ to the nucleus. The machinery 
for nuclear import is believed to be well conserved in eukary- 
otes including yeasts [14]. Thus, the most straightforward ex- 
planation of the observed cell behaviour implies that nuclear 
targeting of human ProTc~ is prerequisited for its interference 
with cell division. 
Our results point to the nucleus as a potential place of action 
of ProT~, in agreement with its probable relation to cell prolif- 
eration. Further experiments will be required to determine the 
molecular mechanisms through which ProT~ exerts its activity. 
We believe, however, that the possibility to investigate the role 
of ProTc~ in cell division process in a relatively simple experi- 
mental system now becomes feasible. 
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